Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01230060 | One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction | PHASE3 | COMPLETED | 122 | — | — | Oct 1, 2010 | Aug 1, 2011 | Aug 22, 2013 | 1 | United States |
Number of participants achieving best corrected visual acuity (BCVA) of 20/40 or better following cataract extraction and intraocular lens implantation.
| Arm | Type | Description |
|---|---|---|
| enVista | EXPERIMENTAL | enVista One-Piece Hydrophobic Acrylic Intraocular Lens |
| Name | Type | Description |
|---|---|---|
| enVista | DEVICE | One-piece hydrophobic acrylic intraocular lens (IOL) implanted following cataract extraction surgery. Patients to be followed for 120-180 days following surgery. |
Inclusion Criteria: * Subjects must have a clinically documented diagnosis of age-related cataract that is considered amenable to treatment with standard phacoemulsification/extracapsular cataract extraction. * Subjects must have a best corrected visual acuity (BCVA) equal to or worse than 20/40 in...